Marco Investment Management LLC grew its stake in Express Scripts Holding (NASDAQ:ESRX) by 5.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,550 shares of the company’s stock after buying an additional 1,400 shares during the period. Marco Investment Management LLC’s holdings in Express Scripts were worth $2,206,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of ESRX. Quantbot Technologies LP boosted its holdings in shares of Express Scripts by 53.4% in the 3rd quarter. Quantbot Technologies LP now owns 19,130 shares of the company’s stock valued at $1,211,000 after buying an additional 6,663 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Express Scripts in the 3rd quarter valued at $2,090,000. Ameriprise Financial Inc. boosted its holdings in shares of Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after buying an additional 996,816 shares in the last quarter. Rational Advisors LLC acquired a new position in shares of Express Scripts in the 3rd quarter valued at $260,000. Finally, Thompson Siegel & Walmsley LLC boosted its holdings in shares of Express Scripts by 38.9% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 126,592 shares of the company’s stock valued at $8,016,000 after buying an additional 35,429 shares in the last quarter. Institutional investors and hedge funds own 89.44% of the company’s stock.
Express Scripts Holding (NASDAQ:ESRX) opened at $72.99 on Tuesday. The company has a market cap of $42,665.23, a price-to-earnings ratio of 9.32, a price-to-earnings-growth ratio of 0.93 and a beta of 0.94. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $85.07.
Express Scripts declared that its Board of Directors has initiated a share buyback plan on Monday, December 18th that authorizes the company to repurchase 45,000,000 shares. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.
Several research analysts have recently issued reports on ESRX shares. Maxim Group upped their target price on shares of Express Scripts from $78.00 to $87.00 and gave the company a “buy” rating in a report on Thursday, December 14th. Deutsche Bank began coverage on shares of Express Scripts in a report on Monday, December 4th. They issued a “buy” rating and a $75.00 target price for the company. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Friday, March 2nd. SunTrust Banks set a $86.00 price target on shares of Express Scripts and gave the company a “buy” rating in a research report on Thursday, December 21st. Finally, TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research report on Monday, December 4th. Three equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $81.97.
In other news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the transaction, the vice president now owns 33,715 shares in the company, valued at approximately $2,730,915. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christine Houston sold 19,889 shares of the stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 31,681 shares of company stock valued at $2,435,102. 0.68% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.com-unik.info/2018/03/20/express-scripts-holding-esrx-shares-bought-by-marco-investment-management-llc.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.